-transparent.png){kind=logo}
A panel of 10 murine monoclonal antibodies to procoagulant FVIII has been developed from the fusion of a single spleen. Balb/c mice were injected with a purified preparation of FVIII: Ag, and antibody production in sera and hybrid culture supernatants was monitored using a specific radiometric screening assay. The antibodies all inhibit FVIII clotting activity in normal plasma, and when immobilised on agarose retain their ability to recognise and bind the FVIII procoagulant protein. Studies on protein A-purified immunoglobulins demonstrate a range of properties within the panel of antibodies with regard to species cross-reactivity, clotting inhibition and immunoadsorption. The panel of antibodies has been used to screen heat-treated FVIII concentrates for the occurrence of heat-induced neoantigens.
B D Griffin, and
L R Micklem, and
M C McCann, and
K James, and
D S Pepper
May 1983,
The Journal of laboratory and clinical medicine,
B D Griffin, and
L R Micklem, and
M C McCann, and
K James, and
D S Pepper
July 1985,
The Journal of clinical investigation,
B D Griffin, and
L R Micklem, and
M C McCann, and
K James, and
D S Pepper
January 1986,
Blood,
B D Griffin, and
L R Micklem, and
M C McCann, and
K James, and
D S Pepper
April 1986,
Thrombosis research,
B D Griffin, and
L R Micklem, and
M C McCann, and
K James, and
D S Pepper
December 1983,
Thrombosis and haemostasis,
B D Griffin, and
L R Micklem, and
M C McCann, and
K James, and
D S Pepper
August 2005,
Journal of cellular biochemistry,
B D Griffin, and
L R Micklem, and
M C McCann, and
K James, and
D S Pepper
March 1990,
Journal of medical microbiology,
B D Griffin, and
L R Micklem, and
M C McCann, and
K James, and
D S Pepper
July 1988,
The Journal of clinical investigation,
B D Griffin, and
L R Micklem, and
M C McCann, and
K James, and
D S Pepper
January 1991,
Autoimmunity,
B D Griffin, and
L R Micklem, and
M C McCann, and
K James, and
D S Pepper
January 1984,
Thrombosis research,
